Business, Main Street / SMB

How to Underwrite an Independent Pharmacy

Underwrite an independent pharmacy by analyzing prescription volume, gross margin per script and payer mix, then testing exposure to PBM reimbursement changes, clawbacks and audits. Key metrics are weekly script count, gross profit per prescription, inventory turns and EBITDA after a market pharmacist salary, with adjustments for any specialty or compounding revenue.

What makes independent pharmacy underwriting different

An independent pharmacy earns most of its revenue dispensing prescriptions, with reimbursement set by pharmacy benefit managers and government programs rather than the pharmacy. Gross margin per prescription is thin and can be cut by PBM contract changes, retroactive fees and audit recoupments. Prescription count, generic dispensing rate and specialty or compounding lines drive profitability. Inventory is a large asset that must be counted at closing. The owner pharmacist often holds relationships with local prescribers and long-term care facilities. Licensing, DEA registration and payer contracts must transfer to the new owner.

Lenders focus on stable script counts, gross margin trends and whether cash flow covers debt after a market pharmacist salary. They value inventory as collateral and watch for payer concentration and audit history. Equity buyers, including regional chains, value pharmacies for prescription files and may buy to transfer scripts to an existing store, which can make price exceed what standalone cash flow supports. Lenders to an independent buyer must underwrite the pharmacy continuing as a standalone business with its current reimbursement contracts.

Key metrics

Prescription count

Weekly or monthly script volume shows the base of the business and its trend.

Gross profit per prescription

Margins vary by payer and drug mix and determine cash flow.

Payer mix

Concentration in a few PBMs or government programs exposes the pharmacy to reimbursement changes.

Inventory turns

Excess or slow-moving inventory ties up cash and may include expired product.

Specialty and compounding revenue

These lines may carry higher margins but also more regulatory and audit risk.

Audit recoupment history

PBM audits can claw back past payments, reducing cash and signaling compliance issues.

How to underwrite it, step by step

Extract dispensing system data for scripts, payer, drug type and gross profit by month.
Analyze reimbursement trends and fees by PBM, including retroactive adjustments.
Review PBM contracts, network participation and assignment requirements.
Count and value inventory and identify expired or slow-moving items.
Review audit history, recoupments and corrective actions.
Assess specialty, compounding and long-term care revenue for durability and compliance.
Normalize EBITDA for a market pharmacist salary and size debt on stabilized cash flow.

Due diligence checklist

Dispensing system reports by payer and drug
PBM and network contracts
Reimbursement and fee statements
Inventory count and valuation
PBM audit reports and recoupment history
State pharmacy license and DEA registration
Controlled substance records
Long-term care facility contracts
Compounding or specialty accreditation documents
Store lease
Three years of tax returns and P&L

Key risks and mitigants

PBM reimbursement cuts or retroactive fees.

Analyze fee trends by payer and stress margin per script.

Audit recoupments after closing for pre-closing claims.

Review audit history and require seller indemnity or escrow.

Loss of key prescriber or facility relationships.

Review referral sources and long-term care contracts and require seller transition.

Licensing or DEA issues delay ownership transfer.

Confirm transfer requirements and timelines before closing.

Inventory overstated or expired.

Conduct physical inventory count at closing with agreed valuation rules.

Typical financing and deal structure

Pharmacy acquisitions by individual pharmacists are often financed with SBA 7(a) loans or specialized pharmacy lenders, with inventory financed as part of the purchase. Seller notes and earnouts are common to bridge valuation gaps and retain prescriber relationships. Wholesaler financing programs may provide working capital or inventory credit in exchange for purchasing commitments. Regional chains buying prescription files often pay cash. Lenders may require the buyer pharmacist to be licensed, maintain key insurance and provide personal guarantees. Covenants can include minimum DSCR and reporting on script volume and payer changes.

Red flags

Rising PBM fees and falling gross profit per script.
Large recent audit recoupments or network terminations.
Heavy dependence on a single facility or prescriber.
Compounding operations without required accreditations.
Inventory levels far above typical turns.

Frequently asked questions

How do you value an independent pharmacy?

Independent pharmacies are often valued on a multiple of adjusted EBITDA or SDE plus inventory at cost. Buyers examine script volume, gross profit per script, payer mix and audit history. Pharmacies with stable volumes and diversified payers command higher values, while those exposed to PBM cuts or audits see lower valuations.

What are PBM clawbacks and why do they matter?

PBM clawbacks are retroactive fees or adjustments that reduce reimbursement after a claim is paid. They can significantly lower actual margin compared with what the pharmacy saw at the point of sale. Underwriters review fee statements and trends to understand true profitability. Fees tied to performance programs can be assessed months after dispensing.

Can a pharmacist get an SBA loan to buy a pharmacy?

Yes. SBA 7(a) loans are commonly used for pharmacy acquisitions. Lenders evaluate historical cash flow, payer mix, audit history and the buyer's licensure. The loan can include inventory and working capital, and a seller note is often part of the structure. Buyers also need new or transferred PBM network contracts, which can take time.

How is pharmacy inventory handled in an acquisition?

Inventory is usually counted by a third party at closing and paid for at cost, separate from the price for goodwill. Expired, damaged or non-returnable items are typically excluded. Underwriters ensure the inventory value is supported and financed appropriately. The inventory figure is usually agreed in the purchase agreement as a separate line from goodwill.

Underwrite a independent pharmacy deal in minutes

Drop a deck or data room. Underridge returns a verdict, investment memo, term sheet and a live model, with every headline figure traced to a page, a formula or a labeled assumption. Ten underwrites free.

Try Underridge free

Educational content, not investment, credit, legal or tax advice. Benchmarks are common practitioner rules of thumb and vary by lender, market and cycle.